Isagani (Gani) M. Chico, M.D.

VP and Global Head for Oncology

Fortrea

Talk to Gani about these topics and more:

  • Oncology clinical trials (early phase to post approval)
  • Oncology medical affairs
  • Pharmaceutical, academic and regulatory interactions

Biostatistics

Cell and Gene (CGT)

Clinical Data

Clinical Strategic Planning

Clinical Trial Retention

Clinical Trial Supply

Clinical Trial Technology

Clinical Trials

Communication Strategies

Contract Research Organization (CRO)

Corrective and preventive action (CAPA)

Decentralized Clinical Trials (DCTs)

Digital Health

Diversity

FDA

Healthcare

Licensing Strategies

M.D.

Patient Recruitment

Pharmacology 

Phase I/Early Phase Research 

Real-World Data

Regulatory

Research and Development

Research as Care

View Expert

John Doyle, DrPH

President, Consulting

Fortrea

Talk to John about these topics and more:

  • Tactics for driving health innovation
  • Optimizing market access strategies for new therapies
  • Demonstrating value through HEOR
  • Drug development life cycle strategies

Artificial Intelligence (AI)

Automation

Clinical Data

Communication Strategies

Corrective and preventive action (CAPA)

Decentralized Clinical Trials (DCTs)

Digital Health

Diversity

eCOA

FDA

Licensing Strategies

Machine Learning

Medical Writing

Patient Recruitment

Pharmacology 

Phase I/Early Phase Research 

Real-World Data

Regulatory

Research and Development

Risk Mitigation

Safety

Strategic Planning

View Expert

Tara Anne Kervin, MPH

VP Global Operations & Consulting

International Drug Development Institute (IDDI)

Talk to Tara about these topics and more: 

  • Independent Data Monitoring Committees (IDMCs; also known as Data and Safety Monitoring Boards [DSMBs])
  • Best practices in clinical data science and biometrics operations
  • Clinical trial design and interim analysis
  • Biostatistical consulting and regulatory interaction

Biopharmaceuticals

Biostatistics

Clinical Data

Clinical Neuropsychology

Clinical Trials

Contract Research Organization (CRO)

FDA

Phase I/Early Phase Research 

Programming

Regulatory

Research and Development

Safety

View Expert

Jay W. Mason, M.D.

Chief Medical Officer

Spaulding Clinical, LLC

Talk to Jay about these topics and more:

  • Understanding cardiac safety requirements, including protocol design 
  • Sponsor support at FDA meetings 
  • Early phase development 
  • Working with data and safety monitoring boards 
  • Cardiac arrhythmias and electrophysiology  

Cardiovascular

Clinical Data

Clinical Trials

Contract Research Organization (CRO)

FDA

M.D.

Phase I/Early Phase Research 

Preclinical

Regulatory

Safety

View Expert